test

Scott Epstein

@Avoro Capital Advisors Llc

Latest period2024 - Q3ReportedManaged Assets$6.858BTotal holdings36
Assets growth rate-8.66%Assets growth rate (2-Q avg)-10.54%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avoro Capital Advisors Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Avoro Capital Advisors Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 6.858B in assets, with a quarterly growth rate of -8.66% and a 2-quarter average growth rate of -10.54%. The portfolio is managed by Scott Epstein, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
UTHRUnited Therapeutics Corp
Recent Activity
14.94%
$1.024B
2.859M shares@ $358.36 avg price
ASNDAscendis Pharma
Recent Activity
Increased 18.88%
10.87%
$744.891M
4.989M shares@ $149.31 avg price
ARGXArgenx Se
Recent Activity
9.79%
$671.348M
1.238M shares@ $542.08 avg price
KRYSKrystal Biotech Inc
Recent Activity
Increased 7.78%
6.96%
$477.323M
2.622M shares@ $182.04 avg price
MDGLMadrigal Pharmaceuticals Inc
Recent Activity
Decreased -1.29%
6.28%
$430.594M
2.029M shares@ $212.22 avg price
APLSApellis Pharmaceuticals Inc.
Recent Activity
4.68%
$320.444M
11.111M shares@ $28.84 avg price
SRPTSarepta Therapeutics Inc
Recent Activity
Decreased -14.81%
4.66%
$319.163M
2.556M shares@ $124.9 avg price
RNAAvidity Biosciences Inc
Recent Activity
Increased 5.69%
4.61%
$315.769M
6.875M shares@ $45.93 avg price
FOLDAmicus Therapeutics Inc.
Recent Activity
Decreased -15.41%
3.61%
$247.509M
23.175M shares@ $10.68 avg price
ITCIIntra-cellular Therapies Inc
Recent Activity
Increased 1.67%
3.26%
$223.168M
3.05M shares@ $73.17 avg price